New paper from Fournier & Sinclair labs: We find that multiple sclerosis (MS) accelera

Partially SupportedEpigenetic reprogramming using an inducible AAV-OSK system can restore vision in primates with retinal injury.

Partially SupportedChemical reprogramming factors will be tested in human clinical trials to treat blindness.

Partially SupportedMultiple sclerosis accelerates neuronal aging, which can be reversed via OSK-reprogramming, preserving vision in an MS mouse model.

Partially SupportedDelivering OSK factors via AAV2 reprogrammed neurons to a younger epigenetic state, reducing cell death and preserving visual function in an MS mouse model.

Partially Supported

New paper from Fournier &amp; Sinclair labs: We find that multiple sclerosis (MS) accelera

New paper from Fournier & Sinclair labs: We find that multiple sclerosis (MS) accelera